Sequential use of antithymocyte globulin and cyclosporine augments skin allograft survival.
D000818:Animals; D000961:Antilymphocyte Serum / Q000008:administration & dosage*; D003524:Cyclosporins / Q000008:administration & dosage / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D006085:Graft Survival; D007165:Immunosuppression Therapy; D008253:Macaca mulatta; D016038:Skin Transplantation
D000961:Antilymphocyte Serum; D003524:Cyclosporins